ID HDAC5_CRIGR Reviewed; 1111 AA. AC Q80ZH1; DT 16-DEC-2008, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2003, sequence version 1. DT 27-MAR-2024, entry version 105. DE RecName: Full=Histone deacetylase 5; DE Short=HD5; DE EC=3.5.1.98; GN Name=HDAC5; OS Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; OC Cricetidae; Cricetinae; Cricetulus. OX NCBI_TaxID=10029; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Ovary; RX PubMed=15525819; DOI=10.1093/glycob/cwi011; RA Chen W., Tang J., Stanley P.; RT "Suppressors of alpha(1,3)fucosylation identified by expression cloning in RT the LEC11B gain-of-function CHO mutant."; RL Glycobiology 15:259-269(2005). CC -!- FUNCTION: Responsible for the deacetylation of lysine residues on the CC N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone CC deacetylation gives a tag for epigenetic repression and plays an CC important role in transcriptional regulation, cell cycle progression CC and developmental events. Histone deacetylases act via the formation of CC large multiprotein complexes. Involved in muscle maturation by CC repressing transcription of myocyte enhancer MEF2C. During muscle CC differentiation, it shuttles into the cytoplasm, allowing the CC expression of myocyte enhancer factors (By similarity). Serves as a CC corepressor of RARA and causes its deacetylation (By similarity). In CC association with RARA, plays a role in the repression of microRNA-10a CC and thereby in the inflammatory response (By similarity). CC {ECO:0000250|UniProtKB:Q9UQL6}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + N(6)-acetyl-L-lysyl-[histone] = acetate + L-lysyl- CC [histone]; Xref=Rhea:RHEA:58196, Rhea:RHEA-COMP:9845, Rhea:RHEA- CC COMP:11338, ChEBI:CHEBI:15377, ChEBI:CHEBI:29969, ChEBI:CHEBI:30089, CC ChEBI:CHEBI:61930; EC=3.5.1.98; CC -!- SUBUNIT: Interacts with AHRR, BAHD1, BCOR, HDAC7, HDAC9, CTBP1, MEF2C, CC NCOR2, NRIP1, PHB2 and a 14-3-3 chaperone protein. Interacts with BCL6, CC DDIT3/CHOP, GRK5, KDM5B and MYOCD. Interacts with EP300 in the presence CC of TFAP2C. Interacts with ANKRA2. Interacts with CUL7 (as part of the CC 3M complex); negatively regulated by ANKRA2. Interacts with ZBTB7B; the CC interaction allows the recruitment of HDAC4 on CD8 loci for CC deacetylation and possible inhibition of CD8 genes expression (By CC similarity). Interacts with RARA (By similarity). CC {ECO:0000250|UniProtKB:Q9UQL6, ECO:0000250|UniProtKB:Q9Z2V6}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. CC Note=Shuttles between the nucleus and the cytoplasm. In muscle cells, CC it shuttles into the cytoplasm during myocyte differentiation. The CC export to cytoplasm depends on the interaction with a 14-3-3 chaperone CC protein and is due to its phosphorylation at Ser-250 and Ser-489 by CC AMPK, CaMK1 and SIK1 (By similarity). {ECO:0000250}. CC -!- DOMAIN: The nuclear export sequence mediates the shuttling between the CC nucleus and the cytoplasm. CC -!- PTM: Phosphorylated by AMPK, CaMK1, SIK1 and PRKD1 at Ser-250 and Ser- CC 489. The phosphorylation is required for the export to the cytoplasm CC and inhibition. Phosphorylated by the PKC kinases PKN1 and PKN2, CC impairing nuclear import (By similarity). Phosphorylated by GRK5, CC leading to nuclear export of HDAC5 and allowing MEF2-mediated CC transcription (By similarity). {ECO:0000250}. CC -!- PTM: Ubiquitinated. Polyubiquitination however does not lead to its CC degradation (By similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2 CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY145846; AAN46420.1; -; mRNA. DR RefSeq; NP_001233710.1; NM_001246781.1. DR RefSeq; XP_007643219.1; XM_007645029.2. DR AlphaFoldDB; Q80ZH1; -. DR SMR; Q80ZH1; -. DR PaxDb; 10029-NP_001233710-1; -. DR GeneID; 100689350; -. DR KEGG; cge:100689350; -. DR CTD; 10014; -. DR eggNOG; KOG1343; Eukaryota. DR OrthoDB; 124800at2759; -. DR Proteomes; UP000694386; Unplaced. DR Proteomes; UP001108280; Chromosome 7. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0004407; F:histone deacetylase activity; IEA:UniProtKB-EC. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:InterPro. DR GO; GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB. DR GO; GO:0050896; P:response to stimulus; IEA:UniProt. DR CDD; cd10007; HDAC5; 1. DR Gene3D; 6.10.250.1550; -; 1. DR Gene3D; 3.40.800.20; Histone deacetylase domain; 1. DR InterPro; IPR046949; HDAC4/5/7/9. DR InterPro; IPR000286; His_deacetylse. DR InterPro; IPR023801; His_deacetylse_dom. DR InterPro; IPR037138; His_deacetylse_dom_sf. DR InterPro; IPR024643; Hist_deacetylase_Gln_rich_N. DR InterPro; IPR023696; Ureohydrolase_dom_sf. DR PANTHER; PTHR45364:SF11; HISTONE DEACETYLASE; 1. DR PANTHER; PTHR45364; HISTONE DEACETYLASE 9-RELATED; 1. DR Pfam; PF12203; HDAC4_Gln; 1. DR Pfam; PF00850; Hist_deacetyl; 1. DR PIRSF; PIRSF037911; HDAC_II_euk; 1. DR PRINTS; PR01270; HDASUPER. DR SUPFAM; SSF52768; Arginase/deacetylase; 1. PE 2: Evidence at transcript level; KW Acetylation; Chromatin regulator; Cytoplasm; Hydrolase; Isopeptide bond; KW Metal-binding; Nucleus; Phosphoprotein; Repressor; Transcription; KW Transcription regulation; Ubl conjugation; Zinc. FT CHAIN 1..1111 FT /note="Histone deacetylase 5" FT /id="PRO_0000357050" FT REGION 40..63 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 107..136 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 187..272 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 474..495 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 527..611 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 645..666 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 671..1017 FT /note="Histone deacetylase" FT REGION 1086..1111 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 1070..1109 FT /note="Nuclear export signal" FT /evidence="ECO:0000250" FT COMPBIAS 240..272 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 572..606 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 822 FT /evidence="ECO:0000250" FT BINDING 685 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT BINDING 687 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT BINDING 693 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT BINDING 770 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT MOD_RES 250 FT /note="Phosphoserine; by AMPK, CaMK1, SIK1 and PKD/PRKD1" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" FT MOD_RES 283 FT /note="Phosphothreonine; by PKC" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" FT MOD_RES 489 FT /note="Phosphoserine; by AMPK, CaMK1, SIK1 and PKD/PRKD1" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" FT MOD_RES 524 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" FT MOD_RES 600 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" FT MOD_RES 650 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" FT MOD_RES 1097 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" FT CROSSLNK 35 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q9UQL6" SQ SEQUENCE 1111 AA; 120988 MW; 52559AE959E190E6 CRC64; MNSPNESDGM PGREPSLEIL PRTPLHSIPV AVEVKPVLPG AMPSSMGGGG GGSPSPVELR GALAGPMDPA LREQQLQQEL LVLKQQQQLQ KQLLFAEFQK QHDHLTRQHE VQLQKHLKQQ QEMLAAKRQQ ELEQQRQREQ QRQEELEKQR LEQQLLILRN KEKSKESAIA STEVKLRLQE FLLSKSKEPT PGSLNHSLPQ HPKCWGAHHA SLDQSSPPQS GPPGTPPSYK LPLLGPYDSR DDFPLRKTAS EPNLKVRSRL KQKVAERRSS PLLRRKDGTV ISTFKKRAVE ITGTGPGVSS VCNSAPGSGP SSPNSSHSAI AENGFTGSVP NIPTEMLPQH RALPLDSSPN QFSLYTSPSL PNISLGLQAT VTVTNSHLTA SPKLSTQQEA ERQALQSLRQ GGTLTGKFMS TSSIPGCLLG VTLEGDTSPH GHASLLQHVL LLEQARQQST LIAVPLHGQS PLVTGERVAT SMRTVGKLPR HRPLSRTQSS PLPQSPQALQ QLVMQQQHQQ FLEKQKQQQM QLGKILTKTG ELPRQPTTHP EETEEELTEQ QEALLGEGAL TMPREGSTES ESTQEDLEEE EDEEEEDEDC IQVKDEEGES GPDEGPDLEE SSAGYKKLFT DAQQLQPLQV YQAPLSLATV PHQALGRTQS SPAAPGSMKS PPDQPTKHLF TTGVVYDTFM LKHQCMCGNT HVHPEHAGRI QSIWSRLQET GLLSKCERIR GRKATLDEIQ TVHSEYHTLL YGTSPLNRQK LDSKKLLGPI SQKMYAMLPC GGIGVDSDTV WNEMHSSSAV RMAVGCLVEL AFKVAAGELK NGFAIIRPPG HHAEESTAMG FCFFNSVAIT AKLLQQKLNV GKVLIVDWDI HHGNGTQQAF YDDPSVLYIS LHRYDNGNFF PGSGAPEEVG GGPGMGYNVN VAWTGGVDPP IGDVEYLTAF RTVVMPIAHE FSPDVVLVSA GFDAVEGHLS PLGGYSVTAR CFGHLTRQLM TLAGGRVVLA LEGGHDLTAI CDASEACVSA LLSVELQPLD EAVLQQKPSI NAVATLEKVI EIQSKHWSCV QRFATGLGCS LQEAQAGETE EAETVSAMAL LSVGAEQAQA VATQEHSPRP AEEPMEQEPT L //